Bumper Offer - Urjas oil Just @ Rs. 1
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin is an allopathic medicine The correct dosage of Beclometasone + Clotrimazole + Lidocaine + Ofloxacin depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Beclometasone + Clotrimazole + Lidocaine + Ofloxacin is used -
Severe
Moderate
Mild
Is the use of Beclometasone + Clotrimazole + Lidocaine + Ofloxacin safe for pregnant women?
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin may have some side effects during pregnancy. Pregnant women should discontinue the use of Beclometasone + Clotrimazole + Lidocaine + Ofloxacin, and talk to their doctor, if they notice any discomfort.
Is the use of Beclometasone + Clotrimazole + Lidocaine + Ofloxacin safe during breastfeeding?
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Beclometasone + Clotrimazole + Lidocaine + Ofloxacin on the Kidneys?
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin rarely harms the kidneys.
What is the effect of Beclometasone + Clotrimazole + Lidocaine + Ofloxacin on the Liver?
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin has very mild side effects on the liver.
What is the effect of Beclometasone + Clotrimazole + Lidocaine + Ofloxacin on the Heart?
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin is rarely harmful for the heart.
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Beclometasone + Clotrimazole + Lidocaine + Ofloxacin unless your doctor advises you to do so -
Is this Beclometasone + Clotrimazole + Lidocaine + Ofloxacin habit forming or addictive?
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin is not addictive in nature.
Interaction between Food and Beclometasone + Clotrimazole + Lidocaine + Ofloxacin
Some foods when eaten with Beclometasone + Clotrimazole + Lidocaine + Ofloxacin can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Beclometasone + Clotrimazole + Lidocaine + Ofloxacin
Consult your doctor before consuming alcohol while taking Beclometasone + Clotrimazole + Lidocaine + Ofloxacin as it can have severe side effects.
Take Beclometasone + Clotrimazole + Lidocaine + Ofloxacin as advised by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
Yes, Beclometasone + Clotrimazole + Lidocaine + Ofloxacin can be taken with phenylephrine. No harmful drug interactions have been reported between them. However, if you feel any discomfort or unpleasant effects after taking this drug to inform your doctor immediately.
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin works by suppressing body's normal immune response to inflammation which is responsible for symptoms such as swelling, redness and itching. This results in decreased inflammation and provides relief from the symptoms associated with it.
Beclometasone + Clotrimazole + Lidocaine + Ofloxacin is a brand name of beclomethasone. It is a prescription drug that belongs to the class of medicine called steroids (corticosteroid). It comes in form of an inhaler, tablet, solution, injection, and topical cream. It has potent anti-inflammatory properties. It is used in the treatment of inflammatory joint diseases, multiple sclerosis, inflammation, allergic conditions, and adrenal insufficiency. It is also used to diagnose Cushing's syndrome.
No, Beclometasone + Clotrimazole + Lidocaine + Ofloxacin Should not be stopped or discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine. Suddenly stopping Beclometasone + Clotrimazole + Lidocaine + Ofloxacin can cause withdrawal symptoms.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)